InvestorsHub Logo
icon url

speed_of_light

09/18/18 8:30 AM

#53604 RE: RodeKroet #53601

"LineaRX" from latin root "desperatus"?

icon url

mcsharkey

09/18/18 9:29 AM

#53609 RE: RodeKroet #53601

Needed any news for a fix this morning Rocket. If anything, this spin OFF seems OK. 8000 milligrams sold to date? Ahhh. So what.

Sure think we're in a better position to attract a BUYER. My hope.
VR
icon url

dasmortes

09/18/18 11:40 AM

#53612 RE: RodeKroet #53601

First I did not say there is no market. I said there is a commodity market, tiny margins and those who can deliver large volumes have a chance of being viable. Companies are competing on cost and PCR based oligo manufacturing is not really cost effective.
Second, your resentment is obvious. I have not called you any names. Yet you are very eager to throw names at me. Not sure why that it but that is not really something I give a crap about. Just pointing it out.
And you should really think as to why a company may want to spin off a division as a subsidiary. APDN is notorious for playing shell games. Could that be one of them?